Paul Cox

Paul Cox joined Dynavax in 2023 and currently serves as Vice President, Investor Relations and Corporate Communications. Mr. Cox has more than 15 years of experience in the biopharmaceutical and technology industries. Before joining Dynavax, he held leadership roles in investor relations, communications and corporate strategy at biotechnology companies including Neumora Therapeutics, Kymera Therapeutics, Sage Therapeutics, Voyager Therapeutics, Neon Therapeutics (acquired by BioNTech), as well as at multiple strategic consulting firms, including Stern Investor Relations. He has been ranked in Institutional Investor’s All-America Executive Team in multiple investor relations categories and currently serves as President and board director of the National Investor Relations Institute (NIRI) Boston chapter, one of the largest and oldest investor relations professional associations. He holds a B.A. in Political Science from the University of Massachusetts Amherst and a Master’s degree in Finance from Harvard University Extension School.